Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
11/24/2011 | US20110288045 Wet granulation of tenofovir, emtricitabine and efavirenz |
11/24/2011 | US20110288041 Antibacterial aminoglycoside analogs |
11/24/2011 | US20110288040 Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors |
11/24/2011 | US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System |
11/24/2011 | US20110288008 Antibacterial and plasmid elimination agents |
11/24/2011 | US20110288007 Biocidal fusion peptide comprising ll-37 |
11/24/2011 | US20110288006 Peptides and methods for inducing cell death |
11/24/2011 | US20110287410 Hepatitis-c virus testing |
11/24/2011 | US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds |
11/24/2011 | US20110287089 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation |
11/24/2011 | US20110287083 Bioabsorbable Composition and Coatings Including Same |
11/24/2011 | US20110287074 Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same |
11/24/2011 | US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof |
11/24/2011 | US20110287066 Nanoporous Foamed Active Compound-Containing Preparations Based On Pharmaceutically Acceptable Thermoplastically Workable Polymers |
11/24/2011 | US20110287059 Honey analysis |
11/24/2011 | US20110287054 Multivalent adjuvanted influenza virus compositions |
11/24/2011 | US20110287052 Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
11/24/2011 | US20110287051 Parapoxvirus vectors |
11/24/2011 | US20110287050 Recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi |
11/24/2011 | US20110287048 Antigen Specific Tregs and related compositions, methods and systems |
11/24/2011 | US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides |
11/24/2011 | US20110287045 Enhanced immune response against infections |
11/24/2011 | US20110287044 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv |
11/24/2011 | US20110287042 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same |
11/24/2011 | US20110287040 Materials and methods for treatment of inflammation |
11/24/2011 | US20110287039 Expression system for modulating an immune response |
11/24/2011 | US20110287037 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
11/24/2011 | US20110287019 Therapeutic targeting of escort proteins |
11/24/2011 | US20110287013 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
11/24/2011 | US20110286996 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof |
11/24/2011 | US20110286971 Targeted drug-carrying bacteriophages |
11/24/2011 | US20110286969 Deuterated compounds as hepatitis c virus (hcv) inhibitors |
11/24/2011 | US20110286968 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
11/24/2011 | US20110286967 Long-acting interferons and derivatives thereof and methods thereof |
11/24/2011 | US20110286965 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
11/24/2011 | US20110286964 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
11/24/2011 | US20110286962 Compounds and pharmaceutical compositions for the treatment of viral infections |
11/24/2011 | US20110286961 Hepatitis C Virus Inhibitors |
11/24/2011 | US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use |
11/24/2011 | US20110286945 Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging |
11/24/2011 | US20110286926 Degradable hydrogel compositions and methods |
11/24/2011 | US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
11/24/2011 | CA2799878A1 Identifying antifungal agents that inhibit iaa or a yap family member |
11/24/2011 | CA2799767A1 Latent human immunodeficiency virus reactivation |
11/24/2011 | CA2799762A1 Crystalline hydrochloride salt of darunavir |
11/24/2011 | CA2799531A1 Methods of treating recurring bacterial infection |
11/24/2011 | CA2799393A1 Skin preparation composition for external use with excellent antibacterial and antifungal effects |
11/24/2011 | CA2799386A1 Treatment of clostridium difficile infection in patients undergoing antibiotic therapy |
11/23/2011 | EP2388330A1 Liver engrafting cells, assays, and uses thereof |
11/23/2011 | EP2388250A1 4-Pyrimidinone derivatives and their use as anti-HIV agents |
11/23/2011 | EP2388249A1 HIV inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives |
11/23/2011 | EP2387584A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins |
11/23/2011 | EP2387583A1 Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
11/23/2011 | EP2387564A1 Benzo ýc¨phenanthridines as antimicrobial agents |
11/23/2011 | EP2387417A2 Broad spectrum vaccine against non-typhoidal salmonella |
11/23/2011 | EP2387409A1 Chitosan derivatives alone or in combination for the treatment of mdr microbial infections |
11/23/2011 | EP2387398A1 Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections |
11/23/2011 | EP2387396A1 Agent for preventing and treating pityriasis versicolor |
11/23/2011 | EP2127667B1 Oral disinfectant and food additive comprising the disinfectant |
11/23/2011 | EP2065377B1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
11/23/2011 | EP1943221B1 Piperazine amidines as antiviral agents |
11/23/2011 | EP1866319B1 Phosphono-pent-2-en-1-yl nucleosides and analogs |
11/23/2011 | EP1819700B1 Potassium salt of an hiv integrase inhibitor |
11/23/2011 | EP1727558B1 Use of dmbt1 for capturing sulphate and phosphate group exposing agents |
11/23/2011 | EP1531841B1 Probiotics for gut neuromuscular functions |
11/23/2011 | EP1509541B1 Novel recombinant anticoagulant proteins |
11/23/2011 | EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors |
11/23/2011 | EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
11/23/2011 | EP1296715B1 Multivalent vaccine composition |
11/23/2011 | EP1226148B1 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
11/23/2011 | CN202043972U Health-care pillow with headrest provided with three layers of medicine cushions |
11/23/2011 | CN1832960B Immunomodulating compositions, uses therefor and processes for their production |
11/23/2011 | CN102257140A Treating hepatitis c virus infection with over-expression of microrna-196 |
11/23/2011 | CN102256991A Uracyl cyclopropyl nucleotides |
11/23/2011 | CN102256989A Anionic conjugates of glycosylated bacterial metabolite |
11/23/2011 | CN102256968A Heterocyclic antiviral compounds |
11/23/2011 | CN102256951A Certain crystalline hydrates,pharmaceutical compositions thereof and methods for preparation and use thereof |
11/23/2011 | CN102256942A New polymorphic form of 1- (4- { l- [ (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino] -ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic |
11/23/2011 | CN102256941A New salts |
11/23/2011 | CN102256491A Isoxazole derivatives for use as fungicides |
11/23/2011 | CN102250918A Recombinant human interferon-like proteins |
11/23/2011 | CN102250916A Brown croaker chemotactic factor CC gene, and detection method and application thereof |
11/23/2011 | CN102250915A Miichthys miiuy alpha chemokine gene CXCL10 as well as detection method and application thereof |
11/23/2011 | CN102250843A Genetic engineering marked attenuated vaccine strain of porcine reproductive and respiratory syndrome virus and application thereof |
11/23/2011 | CN102250817A Bacillus coagulans for feeding and application thereof |
11/23/2011 | CN102250735A Propolis wine combined with golden camellia and preparation method thereof |
11/23/2011 | CN102250734A Linearstripe rabdosia herb combined propolis wine and preparation method thereof |
11/23/2011 | CN102250733A Health-care wine matched with gynostemma pentaphylla and preparation method thereof |
11/23/2011 | CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |
11/23/2011 | CN102250255A Genetic engineering protein TAT-VP28-GH capable of resisting white spot syndrome virus (WSSV) as well as preparation and application thereof |
11/23/2011 | CN102250239A Protein capable of combining with vp60 protein of rabbit hemorrhagic disease virus and use thereof |
11/23/2011 | CN102250234A Protein bonded with rabbit hemorrhagic disease virus VP60 protein and application thereof |
11/23/2011 | CN102250225A Antimicrobial polyperptides from pseudoplectania nigrella |
11/23/2011 | CN102250221A Vancomycin derivate, and preparation method and application thereof |
11/23/2011 | CN102250216A Rana nigromaculata antimicrobial peptide as well as gene and application thereof |
11/23/2011 | CN102250181A Polyhydroxy steroid compounds and purpose thereof |
11/23/2011 | CN102250174A Method for extracting jasminin from winter jasmine leaves |
11/23/2011 | CN102250170A Preparation method and application of two active flavonoid glycosides in okra fruits |
11/23/2011 | CN102250142A Andrographolide compound and application of andrographolide compound in medicaments |
11/23/2011 | CN102250123A Cefodizime sodium hydrate as well as preparation method and application thereof |